<DOC>
	<DOC>NCT01169246</DOC>
	<brief_summary>Primary objective is to assess the efficacy of the new ATP Autoswitch function in simple, dual or triple chamber ICD.</brief_summary>
	<brief_title>Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients</brief_title>
	<detailed_description>The efficacy rate of the ATP Auto-switch function, defined as the % of VT episodes successfully reduced, will be compared with 85%.</detailed_description>
	<criteria>The patient has been implanted (primo implantation or replacement) with an ICD model PARADYM VR 8250, DR 8550, CRT 8750, CRT 8770 models or any similar or higher range device ATP Autoswitch function is programmed ON Presence of a contraindication to the ICD therapy Life expectancy less than 12 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>ATP,CRT, ICD PARADYM</keyword>
</DOC>